METHODS OF TREATING CANCER COMPRISING TARGETING NQO1

• 1. 用于癌症靶向治疗和预防癌症复发的含有基于血红蛋白的氧载体的药物组合物 [P] . 中国专利： CN104717966B . 2018.08.24
• 2. 用于癌症靶向治疗和预防癌症复发的含有基于血红蛋白的氧载体的药物组合物 [P] . 中国专利： CN104717966A . 2015-06-17
• 3. METHODS OF TREATING CANCER COMPRISING TARGETING NQO1 [P] . NO2619331T3 . 2018-07-28

  机译： 靶向治疗NQO1的癌症的方法

• 4. METHODS OF TREATING CANCER COMPRISING TARGETING NQO1 [P] . HUE037382T2 . 2018-08-28

  机译： 靶向治疗NQO1的癌症的方法

• 5. METHODS OF TREATING CANCER COMPRISING TARGETING NQO1 [P] . PT2619331T . 2018-06-01

  机译： 靶向治疗NQO1的癌症的方法

• 1. Design, Synthesis and Characterization of Novel Sulfonamides Derivatives as Anticancer Agent Targeting EGFR TK, and Development of New Methods of Synthesis by Microwave Irradiation [J] . Souad Akili, Djamila Ben Hadda, Yaser Bitar, 有机化学国际期刊（英文） . 2021,第004期
• 2. Novel therapies targeting hypoxia mechanism to treat pancreatic cancer [J] . Wenhao Luo, Jiangdong Qiu, Lianfang Zheng, 中国癌症研究（英文版） . 2021,第002期
• 3. Identification of commonly regulated protein targets and molecular pathways in PC-3 and DU145 androgen-independent human prostate cancer cells treated with the curcumin analogue 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one [J] . Kamini Citalingam, Faridah Abas, Nordin H. Lajis, 亚太热带生物医学杂志（英文版） . 2018,第009期
• 4. Identification of commonly regulated protein targets and molecular pathways in PC-3 and DU145 androgen-independent human prostate cancer cells treated with the curcumin analogue 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one [J] . Kamini Citalingam, Faridah Abas, Nordin H.Lajis, 亚太热带生物医学杂志：英文版 . 2018,第009期
• 5. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: Absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism [J] . Anne-Marie Cleton-Jansen, Ronald van Eijk, Marcel Lombaerts, BMC Cancer . 2008,第1期
• 6. A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells [J] . Molecular Nutrition and Food Research . 2017,第4期
• 7. Regulation of cancer-related genes-Cyp1a1, Cyp1b1, Cyp19, Nqo1 and Comt - expression in beta-naphthoflavone-treated mice by miroestrol [J] . Chatuphonprasert Waranya, Jarukamjorn Kanokwan, Putalun Waraporn Journal of Pharmacy and Pharmacology . 2016,第4期
• 8. Avidity-Driven Targeting of a Novel Biohybrid Nanoscale Carrier Engineered for High Therapeutic Payload and Extended Release of Anticancer Drugs to Treat Small Cell Lung Cancer [C] . Ricky J. Whitener, Katherine A. Windham, Jacek Wower, Society for Biomaterials annual meeting and exposition . 2015
• 9. Targeted Degradation of the MYC Oncogene Using PP2A-B56alpha Selective Small Molecule Modulators of Proteinphosphatase 2A as a Therapeutic Strategy for Treating Myc-Driven Cancers [D] . Farrington, Caroline C. 2020
• 10. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: Absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism [O] . Anne-Marie Cleton-Jansen, Ronald van Eijk, Marcel Lombaerts, 2008
• 11. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: Absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism [O] . 2008

• 1. The Methods of Restraint of Cancers：Reducing Incidence and Treating Earlier [J] . YangBinghui ,吴碧坚 . 健康促进 . 2003,第001期
• 2. 中西医双靶向治疗各种中晚期癌症药物和方案的临床探讨 [C] . 郑伟达 ,郑东海 ,郑伟鸿 . 全国第四届中医、中西医结合暨非药物疗法防治心脑血管病、糖尿病、肿瘤高级论坛 . 2010
• 3. NQO1及其抑制剂在胃癌预后评估及靶向治疗中的作用研究 [A] . 秦云植 . 2015